Colgate-Palmolive (NYSE:CL) Shares Sold by National Bank of Canada FI

National Bank of Canada FI cut its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 736,563 shares of the company's stock after selling 28,575 shares during the quarter. National Bank of Canada FI owned 0.09% of Colgate-Palmolive worth $66,967,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of CL. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 81,303,059 shares of the company's stock worth $7,391,261,000 after buying an additional 588,230 shares in the last quarter. State Street Corp raised its position in Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company's stock valued at $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Norges Bank acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $912,375,000. Finally, Amundi increased its stake in shares of Colgate-Palmolive by 12.8% during the 4th quarter. Amundi now owns 9,200,144 shares of the company's stock worth $806,015,000 after purchasing an additional 1,040,604 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

CL has been the topic of a number of recent research reports. Piper Sandler reduced their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday. UBS Group dropped their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an "overweight" rating in a report on Friday, March 14th. Raymond James reiterated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $102.06.

Colgate-Palmolive Trading Up 2.6 %

NYSE CL traded up $2.40 during mid-day trading on Thursday, hitting $95.95. The company's stock had a trading volume of 5,483,288 shares, compared to its average volume of 4,512,235. The firm has a market capitalization of $77.83 billion, a P/E ratio of 27.26, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock's fifty day simple moving average is $90.19 and its two-hundred day simple moving average is $93.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm posted $0.87 EPS. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is currently 59.09%.

Colgate-Palmolive declared that its board has approved a share repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.